Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Johnson and Johnson
McKesson
Mallinckrodt
McKinsey

Last Updated: October 2, 2022

Investigational Drug Information for Tolevamer


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Tolevamer?

Tolevamer is an investigational drug.

There have been 4 clinical trials for Tolevamer. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.

The most common disease conditions in clinical trials are Enterocolitis, Pseudomembranous, Diarrhea, and Enterocolitis. The leading clinical trial sponsors are Genzyme, a Sanofi Company and [disabled in preview].

Recent Clinical Trials for Tolevamer
TitleSponsorPhase
A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated DiarrheaGenzyme, a Sanofi CompanyPhase 3
A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaGenzyme, a Sanofi CompanyPhase 2
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaGenzyme, a Sanofi CompanyPhase 3

See all Tolevamer clinical trials

Clinical Trial Summary for Tolevamer

Top disease conditions for Tolevamer
Top clinical trial sponsors for Tolevamer

See all Tolevamer clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Johnson and Johnson
McKesson
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.